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ScienceDirectG-protein coupled receptors (GPCRs) form the largest class of
membrane proteins in humans and the targets of most present
drugs. Membrane potential is one of the defining
characteristics of living cells. Recent work has shown that the
membrane voltage, and changes thereof, modulates signal
transduction and ligand binding in GPCRs. As it may allow
differential signalling patterns depending on tissue, cell type,
and the excitation status of excitable cells, GPCR voltage
sensitivity could have important implications for their
pharmacology. This review summarises recent experimental
insights on GPCR voltage regulation and the role of molecular
dynamics simulations in identifying the structural basis of
GPCR voltage-sensing. We discuss the potential significance
for drug design on GPCR targets from excitable and non-
excitable cells.
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Introduction
Membrane proteins form important interfaces mediating
the exchange of matter and information between the cell
and the external world. They are encoded by about 26%
of the human genome [1] and represent a majority both of
present as well as potential future drug targets [2]. G-
protein coupled receptors (GPCRs) constitute the largest
superfamily of membrane proteins in humans with more
than 800 members [3]. They transmit binding informa-
tion of a broad spectrum of extracellular ligands into aCurrent Opinion in Pharmacology 2016, 30:44–50 range of signalling pathways in the cell [4]. As a conse-
quence, they play a paramount role in therapeutic inter-
vention and are targeted by 30% of all presently
marketed drugs [5]. Structurally, GPCRs form a bundle
of seven transmembrane (TM) helices, which shape a
ligand binding site on the extracellular face and an
effector binding site on the intracellular side. Within
the transmembrane domain, a conserved pocket, which
is lined by polar residues and filled with water molecules
[6] and a Na+ ion [7,8,9] extends from the ligand
binding site towards the effector binding site and almost
completely bridges these regions (Figure 1a).
Although the complete mechanism of signal transduction
linking ligand binding to activation of the intracellular
effector proteins is not yet fully understood, essential
elements of this mechanism have been established.
There is, for example, ample evidence for conformational
changes in the TM domain of the receptors induced by
extracellular ligand binding [12]. The changes propagate
towards the intracellular side and facilitate the binding of
effector proteins, which include a variety of G-proteins
and b-arrestins [13]. In the G-protein-dependent signal
transduction pathways, ligand binding on the extracellu-
lar side leads to the exchange of the nucleotide GDP by
GTP in the bound effector G-protein complex. Nucleo-
tide exchange triggers complex dissociation, and the
activated G-protein components then transmit the signal
to targets residing on the intracellular side [13].
All plasma membranes exhibit a transmembrane potential
difference or voltage (Vm), generated by electrochemical
ion gradients across the bilayer [14]. Like all membrane
proteins, GPCRs are therefore located in an environment
in which strong electric fields of up to 107–108 V/m exist, as
the physiologically relevant voltage gradients drop across
the thin hydrophobic core of the membrane, which does
not exceed dimensions of 3 nm along the membrane
normal [15]. Electrically non-excitable cells maintain a
resting voltage, which is negative on the intracellular side
and undergoes slow oscillations during the cell cycle
[14]. In electrically excitable cells — for example, neurons
and muscle cells — the coordinated function of voltage-
gated ion channels generates action potentials, in which
the negative resting voltage displays rapid excursions
towards positive values (termed depolarisation). Thus
Vm typically adopts values between 90 and +50 mV;
however, Vm can reach physiological levels of up to
150 mV, as demonstrated by hair cells in the inner ear [16].www.sciencedirect.com
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The structural features of class A GPCRs as exemplified by the M2 muscarinic receptor. (a) The major structural characteristics of class A GPCRs
comprise seven transmembrane helices (green), an extracellular ligand binding site (blue circle), an internal hydrated pocket (black), and the
intracellular effector protein interaction site (magenta). As both the polar hydrated pocket (water shown in red) and a Na+ (purple) ion binding to
the charged residue D2.50 are conserved amongst class A GPCRs [9], these features are highlighted. The locations of Na+ and water in the M2
receptor were inferred from MD simulations [10], however the Na+ binding site is identical to that observed in crystal structures of other
receptors [7,8]. (b) Distribution of charged residues within the M2 receptor (blue: positive; yellow: negative). Most residues, with the exception of
three aspartates (D2.50, D3.32, and D3.26) are located outside of the direct influence of the membrane voltage. (c) All M2 receptor residues that were
mutated in Ref [11] to probe the origin of voltage-sensing are shown in cyan. Mutation of these residues was demonstrated to have little or no
effect upon gating charges with the exception of D2.50A [11].The rapid Vm oscillations typical for action potentials are
known to influence the conformation and function of
some membrane proteins, an effect that is best under-
stood for voltage-gated ion channels. These channel
proteins contain specialised voltage-sensing domains,
which are capable of inducing large-scale conformational
transitions that gate the channels open or closed, even
under small changes of Vm [17]. By contrast, voltage-
related effects on other membrane proteins such as
GPCRs seem less intuitive, although a number of studies
have reported compelling evidence for a broad range of
Vm-induced phenomena in GPCRs [11,18
,19–21,22]
(for review see Ref [23]). Many important class A GPCR
drug targets are expressed in excitable tissue, for instance
the aminergic, opioid, adrenergic and purinergic recep-
tors. Other important excitable tissue GPCRs include the
class C metabotropic glutamate receptors, for instance in
brain, for which voltage-induced effects have also been
reported [24]. Class C GPCRs also have an extended
allosteric pocket inside their transmembrane domain, as
shown by recent crystal structures [25]. Currently, GPCR
voltage regulation has been best characterised for class A
GPCRs however, and therefore the focus of this review
will be placed on this group. Because of their expression
in excitable cells, effects related to Vm, and thus the
excitation state of the cell, could have an importantwww.sciencedirect.com impact on the function of GPCRs and affect drug action
on the receptors. Similarly, slower changes of Vm which
have been reported to occur during the cell cycle could
play a role in receptor-based signal transduction [14]. The
aim of this review is therefore to summarise recent
insights on the regulation of GPCRs by Vm, discuss its
relevance for drug discovery, and highlight the important
role of molecular dynamics (MD) simulations in deci-
phering the dynamic mechanisms of GPCR voltage sens-
ing and their link to GPCR function.
Experimental evidence for voltage-induced
effects in GPCRs
In recent years, Vm has been experimentally demonstrat-
ed to affect the conformation, function and transmitted
signals of a range of GPCRs [18,19,23,26,27]. Voltage-
related effects have, for instance, been reported for the
muscarinic, adrenergic, and purinergic receptor families
[18,19,20]. In most of the earlier work, evidence for
voltage regulation was obtained indirectly, and measure-
ments often relied on ionic current through downstream
G-protein coupled inward rectifying potassium channels
(GIRK) [28] or the use of intracellular calcium-sensitive
dyes [26]. Voltage-induced conformational changes in
GPCRs have recently also been confirmed directly by
FRET-based reporters [18]. Through both GIRK andCurrent Opinion in Pharmacology 2016, 30:44–50
46 New technologiesFRET measurements, it has been shown that voltage can
have opposite effects on the transmitted signal induced
by agonist action on the receptors [11,18,22]. For
example, the GIRK current elicited by acetylcholine
binding to M2 receptors in rabbit or feline atrial myocytes
is reduced by depolarisation, while that caused by the
agonist pilocarpine is strongly enhanced [11,22].
The most quantitative measure of voltage-induced
rearrangements in GPCRs are electrophysiological
recordings, through which gating currents have been
determined for several receptor types (Table 1). These
transient currents reveal movements of charged regions
in membrane proteins, which occur in response to
voltage changes. Their name stems from their first
observation, caused by the motion of Na+ channel
voltage sensing domains during the process of channel
gating [29]. The electric charge that resides on these
voltage sensing domains, usually carried by charged
amino acid side-chains, is multiplied by the fraction
of the electric field they traverse upon channel gating to
give the so-called gating charge. The gating charge can
be derived from the gating currents and is expressed in
terms of the elementary charge unit [30]. For instance, a
singly charged particle moving across 50% of the voltage
drop across the membrane would give rise to a gating
charge of 0.5e.Table 1
Measured and calculated gating charges of class A GPCRs.
Receptor Gating
charge (e)
Reporter method Refs
m1 muscarinic:
wt 0.72,
0.76a
FRET [18]
m2 muscarinic:
wt 0.55 Electrophysiology [11]
wt 0.53
(Na+)
MD simulation [10]
wt 0.52
(proton)
MD simulation [10]
wt 0.7,
0.85
Electrophysiology [32]
D692.50A NR Electrophysiology [11]
W993.28A 0.8 Electrophysiology [11]
D1033.32A 0.5 Electrophysiology [11]
Y1043.33A 0.54 Electrophysiology [11]
S1073.36A 0.49 Electrophysiology [11]
D1203.49N 0.66 Electrophysiology [32]
D1203.49N-R1203.50N 0.52 Electrophysiology [11]
D1203.49N-R1203.50N NR Electrophysiology [32]
Y4036.51A 0.57 Electrophysiology [11]
a2A-adrenergic
wt 0.5 FRET [19]
d-opioid:
wt 0.42 (Na+) MD simulation [10]
N1313.35V 0.63 (Na+) MD simulation [10]
NR, not resolved.
a Precise value depends on methodology used.
Current Opinion in Pharmacology 2016, 30:44–50 Gating currents in GPCRs were first recorded for the
wild-type (wt) M2 muscarinic receptor (M2 receptor) and
the M2 receptor single-mutant (D120
3.49N)a by cut-open
oocyte electrophysiology. In these experiments, gating
charges between 0.66 and 0.85e were inferred from the
observed voltage dependence of the measured gating
current (Table 1) [32]. In a more recent study, a gating
charge of 0.55e on the wt M2 receptor was obtained by
using the same technique (Table 1 and Figure 1) [11]. In-
terestingly, a wide range of mutants in which residues of
particular interest were modified, including putative li-
gand binding contacts and conserved charged groups, did
neither abolish the recorded gating currents nor markedly
alter the observed gating charges [11]. The most promi-
nent exception was the fully conserved residue D692.50
(Figure 1c), which has been identified as the main Na+
interacting residue in class A GPCRs [9]. However, it
was not clear if this finding, which was obtained before
high-resolution crystal structures revealed ion binding in
the TM section of GPCRs, resulted from lower surface
expression of the mutant or was caused by the mutation
itself [11].
Recently, it has been demonstrated by a combination of
voltage-clamp and FRET experiments that both G-pro-
tein and b-arrestin signalling is strongly modulated by Vm
in the muscarinic receptor family [18]. The authors also
studied the interplay between ligand action and voltage-
induced effects. For instance, they showed that the effect
of depolarisation on the transduced signal caused by the
agonist carbachol in M3 receptors was inverted by a single
mutation (N6.52Q) within the orthosteric ligand binding
site, thereby demonstrating an interaction between the
voltage sensor and the ligand binding site. The authors
propose that the inversion in voltage sensitivity is due to a
changed binding pose of the ligand [18]. Notably, the
magnitude of the voltage effect on the signal can be
similar to the size of the ligand-induced signal such as
in the case of acetylcholine acting upon the M1 receptor,
as determined by FRET assays probing the arrestin3
signal under depolarisation [18].
Role of MD simulations in deciphering the
structural basis of GPCR voltage-sensing
Most GPCR structures so far have been resolved by X-ray
crystallography (for review, see [33,34]). To date, how-
ever, it has not yet been possible to experimentally
determine membrane protein structures in the presence
of a realistic transmembrane voltage. This also currently
precludes the direct structural investigation of conforma-
tional changes triggered by altered Vm.
Present atomistic simulation techniques are commonly
capable of modelling membrane proteins in model lipida Superscripts refer to the Ballesteros–Weinstein generic residue
numbering nomenclature [31].
www.sciencedirect.com
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Structural and mechanistic basis of a potential GPCR voltage sensor
as derived by MD simulations. Depolarised Vm drives outward
migration of an internal cation bound near D2.50 towards the
extracellular space, crossing the ligand binding pocket. The observed
gating charges for this transition are in excellent agreement with
experimental values. Upon repolarisation or hyperpolarisation, the
cation is attracted back into the allosteric binding pocket. The
trajectory of a cation under depolarisation is colour-coded according
to the simulation time, proceeding from red to blue.bilayers over microsecond time spans, allowing MD stud-
ies to address many aspects of GPCR function in mecha-
nistic detail. MD simulations have, for instance, been
successfully used to shed light on the conformational
transition towards the activated receptor state, the role
of so-called micro-switches such as the DRY motif (ionic
lock), receptor G-protein coupling specificity, nucleotide
exchange in the effector complex, internal hydration of
the polar pocket, and the processes of ligand attraction
and binding [12,13,35,36,37]. Voltages across the mem-
brane can be readily included in the MD simulations,
either by applying an external electric field [38,39] or,
similar to cells, by imposing TM electrochemical ion
gradients [40,41], as for instance implemented in the
Computational Electrophysiology (CompEL) protocol
[42].
Recently, voltage-induced conformational changes and
the observation of GPCR gating currents have been
addressed by using MD simulations. First, a range of
supra-physiological Vm were probed by CompEL simula-
tions, followed by a further characterisation of the effects
of physiological Vm by free energy calculations. The
simulations showed that, in accordance with mutation
experiments (Figure 1b,c) [11], none of the charged
groups within or near the transmembrane region display
substantial voltage-induced motions on the simulation
timescales [10]. By contrast, extensive voltage-induced
movements of the Na+ ion, which binds internally in class
A GPCRs to the highly conserved residue D2.50 [9],
along the water-filled pocket were observed (Figure 2).
The movement of this single charge is triggered by
depolarised voltages, facilitated by the hydration level
of the pocket, and occurs directly within the transmem-
brane section of the receptor.
Na+ has been detected in a range of high-resolution
crystal structures of GPCRs [8,43,44,45]. Because of
the conservation level of D2.50 and the polar pocket in
general, it is assumed that Na+ binding to D2.50 is a
general feature of class A GPCRs [9]. In addition,
Na+ is known to have an allosteric effect on the function
of most GPCRs [9].
The expected gating charge for the observed movement
of a cation from D2.50 towards the extracellular entrance of
the receptor ligand binding pocket was determined from
these MD simulations, and lies in the region of 0.53–
0.63e for Na+ in M2 receptor and d-OR variants [10
] (see
Table 1). Both the observation that ion movement is
triggered by depolarisation of Vm and the magnitudes
of the gating charges are thus in excellent agreement
with the experiments. Moreover, previous MD studies on
the d-OR without applied voltage have demonstrated the
internal Na+ ion to be mobile, and able to leave the
receptor under the influence of an applied force [46]. Im-
portantly, it has also been shown that small organic cationswww.sciencedirect.com such as amiloride can replace Na+ in the pocket under low
Na+ concentration, exerting an allosteric effect similar to
Na+ [47]. It is therefore possible that other cations can
undergo analogous movements within the pocket upon
depolarisation, depending on experimental conditions,
and give rise to comparable gating charges [32]. This
includes potential protonation changes of the side chain
of D2.50, during which a proton could be exchanged with
the external solution [10] (Table 1).
Implications for GPCR physiology and
pharmacology
Na+ plays a central role in GPCR function, shifting the
equilibrium between active and inactive receptors, regu-
lating agonist binding, and biasing downstream signals
[8,9]. Any voltage-dependence of the occupancy of
the GPCR allosteric pocket with Na+ or its position
within the receptors could therefore have major function-
al implications for signal transduction and signal bias.
Alongside its potential structural basis, voltage-depen-
dence of GPCR conformation or signalling has now been
established for a range of GPCRs and deserves the
attention of drug designers and pharmacologists alike.
As shown by Rinne et al. [18], voltage can eitherCurrent Opinion in Pharmacology 2016, 30:44–50
48 New technologiesenhance or attenuate the transmitted agonist signal
depending on the ligand and precise environment of
the binding site. In addition, ligand binding affinity has
been shown to be voltage-dependent [32].
Electrophysiological properties such as resting Vm vary
substantially between different cell types. For example,
neurons display a markedly shifted Vm in various brain
regions and developmental stages [48]. The action of
GPCR ligands is therefore likely to depend on the
cellular context. In electrically excitable cells, the trans-
duced GPCR signal could also be altered by the excita-
tion state of the cell. It has for instance been
demonstrated that GPCR voltage sensing modulates
synaptic neurotransmission by reshaping the kinetics
of voltage-dependent transmitter release on the milli-
second timescale [49]. Therefore, it is conceivable that
GPCRs can establish dynamic feedback routes, by
which voltage information is transmitted back into a
range of intracellular signals on both fast and slow time-
scales. Notably, recent cancer research has revealed that
a range of malignant cell types possess a more depo-
larised resting voltage than quiescent cells [14,50,51].
Although GPCRs have traditionally received less atten-
tion than other proteins as cancer drug targets, GPCRs
are known to be involved in cancer initiation and pro-
gression [52]. The role of GPCR voltage regulation has,
to our best knowledge, however not yet been investigat-
ed in this context.
Similarly, it has recently been demonstrated that onco-
genic signalling pathways are influenced by Vm through
the redistribution of charged lipids in the inner leaflet of
the plasma membrane [50]. Because membrane lipids
allosterically modulate GPCR activity [53], Vm could
thus also have an indirect impact on receptor signal
transduction via an effect on lipid distribution. As we
only begin to appreciate the importance of Vm in regulat-
ing membrane proteins either directly or indirectly, much
further work is needed to fully understand the role of Vm
in GPCR signalling and its implications for the drug
design process, which could be wide-ranging.
Conclusions
Recent experimental and computational insights suggest
that the membrane voltage has an important impact on
GPCR pharmacology. In particular, MD simulations un-
der voltage are able to characterise functionally important
movements in GPCRs driven by potential differences.
Further simulations would be useful to investigate the
interplay of voltage-induced changes with ligand binding
and signal transduction. The fact that GPCRs are voltage-
sensitive, together with its possible structural underpin-
ning, should be taken into consideration during drug
development on GPCR targets, as especially in excitable
cell GPCRs, voltage-sensing could be an important
mechanism of feeding back voltage information intoCurrent Opinion in Pharmacology 2016, 30:44–50 intracellular signal transduction pathways. Thereby, the
signal that is actually induced by a ligand might depend
on the excitation state of the cell, which would have
important consequences for drug discovery on excitable
tissue GPCRs. It should also be investigated if agonists
can show variations in their effect on different cell types,
including non-excitable cells, owing to a difference in
resting Vm.
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